Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Current Trends in Identifying Rapidly Acting Treatments for Depression.

Ionescu DF, Papakostas GI.

Curr Behav Neurosci Rep. 2016 Jun;3(2):185-191. Epub 2016 Apr 15.

2.

Aerobic Exercise as a Tool to Improve Hippocampal Plasticity and Function in Humans: Practical Implications for Mental Health Treatment.

Kandola A, Hendrikse J, Lucassen PJ, Yücel M.

Front Hum Neurosci. 2016 Jul 29;10:373. doi: 10.3389/fnhum.2016.00373. eCollection 2016. Review.

3.

Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.

Jakubovski E, Varigonda AL, Freemantle N, Taylor MJ, Bloch MH.

Am J Psychiatry. 2016 Feb 1;173(2):174-83. doi: 10.1176/appi.ajp.2015.15030331. Epub 2015 Nov 10. Review.

4.

Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study.

Abraha I, Cherubini A, Cozzolino F, De Florio R, Luchetta ML, Rimland JM, Folletti I, Marchesi M, Germani A, Orso M, Eusebi P, Montedori A.

BMJ. 2015 May 27;350:h2445. doi: 10.1136/bmj.h2445.

5.

Two Chronic Stress Models Based on Movement Restriction in Rats Respond Selectively to Antidepressant Drugs: Aldolase C As a Potential Biomarker.

Ampuero E, Luarte A, Santibañez M, Varas-Godoy M, Toledo J, Diaz-Veliz G, Cavada G, Rubio FJ, Wyneken U.

Int J Neuropsychopharmacol. 2015 Mar 26;18(10):pyv038. doi: 10.1093/ijnp/pyv038.

6.

Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.

Wiles NJ, Fischer K, Cowen P, Nutt D, Peters TJ, Lewis G, White IR.

Psychol Med. 2014 Oct;44(13):2855-66. doi: 10.1017/S0033291714000221. Epub 2014 Mar 3.

7.

Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials.

Maneeton N, Maneeton B, Srisurapanont M, Martin SD.

BMC Psychiatry. 2012 Sep 27;12:160. doi: 10.1186/1471-244X-12-160.

8.

Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors.

Briley M, Moret C.

Neuropsychiatr Dis Treat. 2010 Oct 5;6:647-55. doi: 10.2147/NDT.S13171.

9.

Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.

Eyding D, Lelgemann M, Grouven U, Härter M, Kromp M, Kaiser T, Kerekes MF, Gerken M, Wieseler B.

BMJ. 2010 Oct 12;341:c4737. doi: 10.1136/bmj.c4737. Review.

10.

Toward achieving optimal response: understanding and managing antidepressant side effects.

Kelly K, Posternak M, Alpert JE.

Dialogues Clin Neurosci. 2008;10(4):409-18. Review.

Supplemental Content

Support Center